Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Dermatologic 1

Conditions

Neoplasms 18Breast Neoplasms 16Lung Neoplasms 10Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Melanoma 5Colorectal Neoplasms 5Brain Neoplasms 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Skin Neoplasms 3Myeloproliferative Disorders 3Leukemia, Myeloid, Acute 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Recurrence 2Neoplasm, Residual 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Lung Diseases 2Glioma 2Glioblastoma 2Genetic Predisposition to Disease 2Esophageal Neoplasms 2Endometrial Neoplasms 2

Interventions

fludarabine 4Cyclophosphamide 4fludarabine phosphate 3Melphalan 3pembrolizumab 2obinutuzumab 2blinatumomab 2Rituximab 2Radiotherapy 2Lenalidomide 2Capecitabine 2Blood Specimen Collection 2trastuzumab deruxtecan 1tislelizumab 1tisagenlecleucel 1thymoglobulin 1tetrathiomolybdate 1talquetamab 1sacituzumab govitecan 1palbociclib 1nilotinib 1isatuximab 1avelumab 1atezolizumab 1acalabrutinib 1Whole-Body Irradiation 1Trastuzumab 1Sirolimus 1Neoadjuvant Therapy 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm, Residual × Blood Specimen Collection × 90 days × Clear all
NCT07178847 2026-06-03

NeckTAR-IN

Centre Jean Perrin

Phase NA Recruiting
59 enrolled
Tumor-Agnostic

Neoplasm, Residual

NCT06875609 2026-03-30

ctDNA in Cutaneous Squamous Cell Carcinoma

Massachusetts Eye and Ear Infirmary

Recruiting
60 enrolled
Dermatologic

Skin Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡